Heartbeam financials
$0.3679−1.37%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross margin | — | — | — | — | — |
| Operating income | -$21.1M | -$19.9M | -$15.3M | -$13.0M | -$2.3M |
| Net income | -$21.0M | -$19.4M | -$14.6M | -$13.0M | -$4.4M |
| Net margin | — | — | — | — | — |
| Diluted EPS | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 |
| EBITDA | -$21.1M | -$19.9M | -$15.3M | -$13.0M | -$2.3M |
| Operating cash flow | -$14.0M | -$14.5M | -$12.1M | -$9.9M | -$3.2M |
| Free cash flow | -$14.6M | -$14.7M | -$12.3M | -$9.9M | — |
| Diluted shares | 33.7M | 26.6M | 20.3M | 8.2M | 4.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $4.4M | $2.4M | $16.2M | $3.6M | $13.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $5.8M | $3.3M | $17.1M | $4.0M | $14.0M |
| Total liabilities | $3.2M | $1.6M | $1.2M | $1.7M | $588.0K |
| Shareholders' equity | $2.6M | $1.7M | $15.9M | $2.4M | $13.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology